Pyxis Oncology, Inc. Quarterly Marketable Securities, Current in USD from Q1 2023 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Pyxis Oncology, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2023 to Q2 2024.
Pyxis Oncology, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $131M, a 11.9% increase year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$131M	+$13.9M	+11.9%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$129M	+$32.8M	+34%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$110M			Dec 31, 2023	10-Q	2024-08-14
Q3 2023	$118M			Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$117M			Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$96.3M			Mar 31, 2023	10-Q	2023-05-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.